Back
Summit Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
SMMT
Summit Therapeutics
Last Price:
$26.44
Seasonality Move:
7.77%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and SMMT is experiencing slight selling pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.06 | Sell |
| 20-day SMA: | 27.49 | Sell |
| 50-day SMA: | 24.15 | Buy |
| 200-day SMA: | 21.68 | Buy |
| 8-day EMA: | 26.12 | Buy |
| 20-day EMA: | 19.3 | Buy |
| 50-day EMA: | 10.53 | Buy |
| 200-day EMA: | 3.12 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.2 | Buy |
| Relative Strength Index (14 RSI): | 51.19 | Buy |
| Chaikin Money Flow: | -1308980 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.86 - 28.44) | Sell |
| Bollinger Bands (100): | (20.12 - 27.32) | Buy |
Summit Therapeutics Technical Analysis
| Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 26.87 while SMMT 8-day simple moving average is 28.06, which is a Sell signal.
-
The stock price of SMMT is 26.87 while Summit Therapeutics 20-day SMA is 27.49, which makes it a Sell.
-
Summit Therapeutics 50-day simple moving average is 24.15 while SMMT share price is 26.87, making it a Buy technically.
-
SMMT stock price is 26.87 and Summit Therapeutics 200-day simple moving average is 21.68, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
46
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a SellThe current Summit Therapeutics [SMMT] share price is $26.87. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
20B
Price in USD:
26.87
Share Volume:
5.4M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
10.30
Sell
46
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 26.87 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 26.87 while SMMT 8-day exponential moving average is 26.12, which is a Buy signal.
-
The stock price of SMMT is 26.87 while Summit Therapeutics 20-day EMA is 19.30, which makes it a Buy.
-
Summit Therapeutics 50-day exponential moving average is 10.53 while SMMT share price is 26.87, making it a Buy technically.
-
SMMT stock price is 26.87 and Summit Therapeutics 200-day simple moving average is 3.12, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.33 per share, and an increase next year of $0.06 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 7.2, suggesting Summit Therapeutics is a Buy
-
Summit Therapeutics Relative Strength Index (RSI) is 51.19, which suggest Summit Therapeutics is overbought
-
The Bollinger Bands (25) for Summit Therapeutics is (25.86 - 28.44), which suggest Summit Therapeutics is a Buy
-
The Bollinger Bands (100) for Summit Therapeutics is (20.12 - 27.32), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.